(Q46879588)

English

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Spontaneous bacterial peritonitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

author name string

Angeli P

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Guarda S

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Fasolato S

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Miola E

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Craighero R

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Piccolo F

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Antona C

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Brollo L

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Franchin M

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Merkel C

11

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Gatta A

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

23

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

75-84

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

A prospective study of bacterial infections in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02706.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02706.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393283

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46879588&oldid=2135615762"